Picture EBD Group Global Partnering Four Events One Price 650x80
Organisation › Details

Biophytis S.A. (Euronext Growth Paris: ALBPS)

BIOPHYTIS is a biotech company founded in 2006 and specialized in aging diseases. It develops innovative therapeutic solutions on pathologies, without treatment, in order to restore the muscular and visual functions. BIOPHYTIS focuses its R&D efforts in the fight against the age-related macular degeneration (AMD) and the age-related muscular dystrophy (Sarcopenia). On these two highly invalidating diseases, the company has proprietary candidates entering in phase 2b. Installed in the Biocitech technopark (Romainville-Paris), BIOPHYTIS has also a subsidiary in Brazil (Sao Paulo). The company is based on leading research collaborations with the UPMC (Pierre et Marie Curie University), the ICAN (Institute of Cardiometabolism and Nutrition), the Institute of Myologie and the Vision Institute. For more information, please visit: BIOPHYTIS is eligible for the French PEA-PME regime *


Period Start 2006-01-01 established
  Group Biophytis (Group)
Products Industry BIOTECH
  Industry 2 Sarconeos
Persons Person Veillet, Stanislas (Biophytis 200609– CEO + Co-founder)
  Person 2 Schneiderman, Daniel (Biophytis 201907 CFO)
Region Region Romainville
  Country France
  Street 102 avenue Gaston Roussel
Parc Biocitech
  City 93230 Romainville
  Tel +33-1-4183-6600
    Address record changed: 2020-12-02
Basic data Employees n. a.
    * Document for �About Section�: 
Record changed: 2021-01-20


Picture [iito] Plain Stupid Simple 650x80px

More documents for Biophytis (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture Berlin Partner Bionnale 2021 Digital Event 650x80px

» top